Literature DB >> 11676497

Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.

L Mauro1, M Salerno, M L Panno, D Bellizzi, D Sisci, A Miglietta, E Surmacz, S Andò.   

Abstract

This study demonstrates how the potentiating effects of E2 on insulin signaling in ER-positive breast cancer cells are consequent to an enhanced IRS-1 expression [corrected]. It induces an increase of both PI-3K/AKT and ERK1/2 activities. A direct action of E2 in the regulating mouse IRS-1 gene is also investigated in both Chinese hamster ovary and MCF-7 cells that are transfected with mouse IRS-1 regulatory sequences. The authors have reported, for the first time, how E2 induction of IRS-1 mRNA was correlated with a direct positive regulatory role of E2 on the IRS-1 promoter. This effect seems to be not strictly related to the cell type. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676497     DOI: 10.1006/bbrc.2001.5815

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors.

Authors:  Jing Fan; Roberta McKean-Cowdin; Leslie Bernstein; Frank Z Stanczyk; Arthur Xuejun Li; Rachel Ballard-Barbash; Anne McTiernan; Richard Baumgartner; Frank Gilliland
Journal:  Breast Cancer Res Treat       Date:  2006-06-05       Impact factor: 4.872

Review 2.  Effects of psoralens as anti-tumoral agents in breast cancer cells.

Authors:  Maria Luisa Panno; Francesca Giordano
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Expression of nuclear insulin receptor substrate 1 in breast cancer.

Authors:  Diego Sisci; Catia Morelli; Cecilia Garofalo; Francesco Romeo; Lucio Morabito; Filomena Casaburi; Emilia Middea; Sandra Cascio; Elvira Brunelli; Sebastiano Andò; Eva Surmacz
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

4.  Increased Igf-I/Igfbp-3 Ratios in Postmenopausal Taiwanese with Breast Cancer, Irrespective of Er and Pr Statuses and Her2 Expression in a Case-Control Study.

Authors:  Su-Chen Lee; Shih-Meng Tsai; Ming-Feng Hou; Li-Ying Tien; Szu-Hsien Wu; Lisa Ann Hou; Joseph M Tsai; Li-Yu Tsai
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

5.  Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer.

Authors:  Jennifer L Clark; Karen Dresser; Chung-Cheng Hsieh; Michael Sabel; Celina G Kleer; Ashraf Khan; Leslie M Shaw
Journal:  Breast Cancer Res Treat       Date:  2011-01-22       Impact factor: 4.872

6.  Changes in cardiac Na+/K+-ATPase expression and activity in female rats fed a high-fat diet.

Authors:  Aleksandra Jovanovic; Milan Obradovic; Emina Sudar Milovanovic; Alan J Stewart; Samantha J Pitt; Dragan Alavantic; Ema Aleksic; Esma R Isenovic
Journal:  Mol Cell Biochem       Date:  2017-05-31       Impact factor: 3.396

7.  Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.

Authors:  Ilenia Migliaccio; Meng-Fen Wu; Carolina Gutierrez; Luca Malorni; Syed K Mohsin; D Craig Allred; Susan G Hilsenbeck; C Kent Osborne; Heidi Weiss; Adrian V Lee
Journal:  Breast Cancer Res Treat       Date:  2009-11-19       Impact factor: 4.872

8.  Insights from gene arrays on the development and growth regulation of uterine leiomyomata.

Authors:  John C M Tsibris; James Segars; Domenico Coppola; Shrikant Mane; George D Wilbanks; William F O'Brien; William N Spellacy
Journal:  Fertil Steril       Date:  2002-07       Impact factor: 7.329

9.  Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.

Authors:  Crystal N Marconett; Ankur K Singhal; Shyam N Sundar; Gary L Firestone
Journal:  Mol Cell Endocrinol       Date:  2012-07-24       Impact factor: 4.102

10.  Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.

Authors:  Geetanjalee Modha; Anne Blanchard; Janine Sidorchuk; Marcello Venditti; Robert Shiu; Yvonne Myal
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.